Early response evaluation of neoadjuvant therapy with PET/MRI to predict resectability in patients with adenocarcinoma of the esophagogastric junction.
Mohamed BelmouhandJohan LöfgrenHelle Hjorth JohannesenLene BaeksgaardHenrik GutteKiran TariqMichael Patrick AchiamPublished in: Abdominal radiology (New York) (2020)
Response evaluation using PET/MRI was a feasible method to predict resectability in patients with adenocarcinoma of the esophagogastric junction in this pilot study. However, larger studies are warranted to justify the use of the modality for this indication.